- $42.46bn
- $42.34bn
- $3.19bn
- 88
- 6
- 100
- 71
Annual income statement for Teradyne, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,703 | 3,155 | 2,676 | 2,820 | 3,190 |
| Cost of Revenue | |||||
| Gross Profit | 2,207 | 1,867 | 1,537 | 1,649 | 1,857 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,531 | 2,323 | 2,175 | 2,226 | 2,540 |
| Operating Profit | 1,172 | 832 | 501 | 594 | 650 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,161 | 840 | 526 | 609 | 653 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,015 | 716 | 449 | 550 | 574 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,015 | 716 | 449 | 542 | 554 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,015 | 716 | 449 | 542 | 554 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.71 | 4.3 | 2.84 | 3.09 | 3.68 |
| Dividends per Share |